Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.280
-0.030 (-2.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cardiol Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 106 | 54 | 32 | 112 | 72 | 91 | |
| Market Cap Growth | 134.34% | 67.34% | -71.06% | 56.56% | -21.55% | 23.29% | |
| Enterprise Value | 95 | 24 | -16 | 90 | 59 | 84 | |
| Last Close Price | 1.28 | 0.84 | 0.51 | 1.85 | 2.18 | 3.54 | |
| PS Ratio | - | - | - | 1803.25 | - | - | |
| PB Ratio | 18.02 | 2.54 | 0.84 | 1.86 | 6.88 | 8.08 | |
| P/TBV Ratio | 18.02 | 2.56 | 0.85 | 1.87 | 7.13 | 8.39 | |
| EV/Sales Ratio | - | - | - | 1441.08 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Asset Turnover | - | - | - | 0.00 | - | - | |
| Quick Ratio | 2.32 | 4.24 | 6.11 | 7.29 | 5.66 | 11.42 | |
| Current Ratio | 2.49 | 4.36 | 6.27 | 7.53 | 5.94 | 20.81 | |
| Return on Equity (ROE) | -159.53% | -69.93% | -48.16% | -70.69% | -147.74% | -74.08% | |
| Return on Assets (ROA) | -79.07% | -37.71% | -34.47% | -46.58% | -82.38% | -36.99% | |
| Return on Capital (ROIC) | -104.92% | -46.14% | -40.17% | -53.83% | -91.42% | -39.75% | |
| Earnings Yield | -25.19% | -39.19% | -70.37% | -22.28% | -22.60% | -11.55% | |
| FCF Yield | -17.01% | -35.17% | -62.10% | -16.58% | -10.04% | -9.96% | |
| Buyback Yield / Dilution | -5.66% | -3.13% | -44.61% | -44.77% | -15.63% | -67.97% | |
| Total Shareholder Return | -5.66% | -3.13% | -44.61% | -44.77% | -15.63% | -67.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.